ANGELHOLM, Sweden, Sept. 14 /PRNewswire/ -- HemoCue today introduces a new system for point-of-care testing of blood glucose with lab quality accuracy, at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Copenhagen. The new HemoCue Glucose 201 RT has a wider measuring range than current HemoCue glucose systems and uses microcuvettes that are room temperature stable. This system has just received FDA 510(k) clearance for the US, and allows blood glucose to be measured with high precision and accuracy anywhere, anytime.
